新闻

RapAdmin

KaempferolImmune-2
KaempferolImmune-21920×1072 318 KB

A new preclinical study demonstrates that kaempferol, a common dietary flavonoid found in kale, spinach, and berries,effectively mitigates age-associated immune dysfunction and systemic inflammation in mice. Administering kaempferol to nineteen-month-old mice for eight weeks significantly improved physical performance, restoring grip strength and neuromuscular coordination while reducing depressive behaviors. The compound rebalanced peripheral T-cell populations by increasing naive T cells, lowering exhausted effector memory T cells, and elevating the CD4 to CD8 ratio. At the cellular level, kaempferol eliminated defective mitochondria and lowered toxic reactive oxygen species through the SIRT3-LKB1-AMPK signaling cascade, thereby repressing the senescence-associated secretory phenotype. Although the intervention failed to achieve a statistically significant extension in overall lifespan or regenerate the atrophied thymus, it markedly reduced senescence markers across the liver, kidneys, muscle, and adipose tissue, highlighting its viability as an actionable nutritional therapy to preserve functional healthspan.

As mammalian bodies grow older, the immune system undergoes a double failure. It loses the capacity to mount effective defenses against novel pathogens while simultaneously stoking a persistent, destructive fire known as inflammaging.Central to this breakdown are aging T cells. Instead of protecting the host, these exhausted white blood cells turn into persistent sources of inflammatory poisons, leaking toxic signaling molecules that degrade muscle fibers, damage organs,and accelerate frailty.

A research team at Shandong University has demonstrated that dietary administration of the natural plant flavonoid kaempferol can break this destructive loop by targeting cellular waste disposal inside aged T cells.

The investigators placed nineteen-month-old mice, roughly equivalent to sixty-year-old humans, on chow supplemented with kaempferol for eight weeks. Rather than attempting to revive the thymus, the primary immune organ that generates fresh T cells and typically undergoes near-total atrophy by middle age, the treatment targeted the survival and functional quality of circulating T cells already in the periphery.

The phenotypic improvements were pronounced. Mice receiving the higher dietary dose demonstrated substantial gains in neuromuscular coordination and grip strength alongside marked reductions in depressive-like behavior during stress challenges. Looking deeper into the tissues, the researchers discovered that the compound extinguished inflammatory and senescence markers across vital organs, including the liver, kidneys, skeletal muscle, and visceral fat depots.

The root cause of these systemic benefits traced back to mitochondrial health inside the T cells themselves. Aged lymphocytes typically accumulate swollen, leaky mitochondria that generate damaging reactive oxygen species and trigger chronic inflammatory secretions. Kaempferol reversed this degradation by activating a specialized cellular cleanup pathway known as mitophagy.

Through molecular docking and cellular assays, the researchers proved that kaempferol interacts with SIRT3, a critical mitochondrial enzyme. SIRT3 de-acetylates the regulator LKB1, which subsequently switches on AMPK, the primary metabolic gauge of the cell. This cascade flags worn-out mitochondria for rapid engulfment and degradation in cellular lysosomes. Once these dysfunctional powerhouses were eliminated, overall cellular energy production stabilized, oxidant production plummeted, and the T cells stopped spewing destructive cytokines like interleukin-6, interleukin-17A, and tumor necrosis factor-alpha. Using gene-editing tools to delete SIRT3 completely eliminated these therapeutic effects,demonstrating that this cleanup pathway is strictly mandatory.

Crucially, the compound did not significantly extend the total lifespan of the animals, yielding only a non-significant trend toward longer survival. It also failed to reverse structural thymic shrinkage. What it accomplished instead was functional rejuvenation: restoring the peripheral ratio of helper-to-cytotoxic T cells, increasing the supply of naive T cells, and substantially improving late-life physical vigor. Kaempferol demonstrates that targeting metabolic quality control in circulating immune cells offers a realistic pathway to preserve late-life physical function and shorten the period of age-related infirmity.

Actionable Insights

For individuals focused on healthspan optimization, this research highlights the therapeutic potential of targeting peripheral immune metabolism. The study utilized a high dose of 100 milligrams per kilogram of body weight per day in mice. Applying standard allometric scaling translates this animal dose to roughly 8.1 milligrams per kilogram in humans,equivalent to approximately 570 milligrams daily for a 70-kilogram adult.

Achieving this intake solely through diet is impractical. High-kaempferol foods such as capers, kale, spinach, and watercress provide only 10 to 30 milligrams per standard serving. Concentrated dietary supplementation would be required to approximate these experimental exposures.

The magnitude of physical benefit in the animal model was substantial. Kaempferol produced an 18.8 percent gain in normalized forelimb grip strength (standardized Cohen’s d of approximately 2.0, representing a massive effect) and reduced immobility under stress by 46.2 percent. Circulating levels of key inflammatory drivers such as tumor necrosis factor-alpha and interleukin-6 dropped by 58 to 64 percent. However, because kaempferol has naturally low human oral bioavailability, biohackers should recognize that high oral doses may require lipid-based or phospholipid delivery systems to achieve comparable cellular concentrations.

Context/Source

  • Open Access Paper: Kaempferol alleviates T-cell immunosenescence and inflammaging in aged mice via the SIRT3-LKB1-AMPK-mitophagy pathway. Published Feb. 2, 2026.
  • Institutions: Institute of Women, Children and Reproductive Health, Cheeloo College of Medicine, Shandong University; Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University
  • Country: China
  • Journal Name: Immunity & Ageing
  • Journal Impact Evaluation: The impact score of this journal is 7.9, evaluated against a typical high-end range of 0–60+ for top general science, therefore this is a High impact journal.

RapAdmin

GutInflammationMicronutrients-2
GutInflammationMicronutrients-21920×1072 301 KB

As humans age, chronic low-grade systemic inflammation, termed inflammaging, drives functional decline,immunosenescence, and multimorbidity. This narrative review explores the mechanistic interplay between micronutrient status, gut microbiota dysbiosis, and immune competence. The authors synthesize biological pathways demonstrating that age-related shifts in gut flora increase intestinal permeability, permitting bacterial endotoxins to enter systemic circulation and trigger inflammatory signaling via pattern recognition receptors. Deficiencies in vitamins A, B-complex, C, D, E, and K, as well as essential minerals including zinc, selenium, and magnesium, exacerbate this cascade by impairing mucosal repair, reducing regulatory immune responses, and elevating oxidative stress. Conversely, physiological sufficiency of these nutrients supports microbial diversity, stimulates short-chain fatty acid synthesis, reinforces epithelial tight junctions, and maintains hematopoietic stem cell integrity.

Chronic, low-grade inflammation quietly accelerates almost every major disease of aging, from cardiovascular decay to neurodegeneration. Rather than viewing this immune breakdown as an untreatable consequence of time, a comprehensive review in Immunity & Ageing positions the human digestive tract as ground zero for systemic immune deterioration.

The central concept hinges on what happens to the gastrointestinal ecosystem over decades of life. In youth, a diverse microbial community lives in symbiosis with the host, separated by an intact intestinal barrier. As the body ages, this microbial population shifts unfavorably. Beneficial bacteria that produce protective short-chain fatty acids, such as acetate and butyrate, begin to decline. In their place, opportunistic, inflammatory bacteria proliferate.

This microbial imbalance damages the intestinal architecture. Proteolytic enzymes and oxidative stress degrade structural proteins, including E-cadherin and epithelial tight junctions. The physical lining of the gut becomes increasingly porous,establishing a condition often termed a leaky gut. When this barrier fails, bacterial fragments like lipopolysaccharides and flagellins slip out of the intestine and infiltrate the bloodstream.

Once in circulation, these microbial components act as persistent warning signals. Immune cells recognize them via toll-like receptors, activating broad inflammatory cascades. Circulating inflammatory proteins, such as interleukin-6 and tumor necrosis factor-alpha, spread throughout the vasculature. This digestive inflammation sets off a damaging chain reaction: it forces hematopoietic stem cells in the bone marrow into skewed myeloid production, exhausts mature immune cells, and impairs the body’s ability to clear damaged, senescent cells.

Essential micronutrients serve as primary regulators of this defensive perimeter. Vitamins A, C, D, E, and the B-complex,along with trace minerals like zinc, selenium, and magnesium, are not simple radical scavengers. Instead, they operate as biological cofactors required to sustain cellular repair, modulate genomic stability, and regulate immune signaling.Vitamin D and retinoic acid reinforce tight junctions and promote immune tolerance, while minerals such as zinc and magnesium preserve mucosal integrity and suppress aberrant inflammasome activation.

Crucially, this relationship operates in two directions. While adequate micronutrients nurture beneficial bacteria like Akkermansia and Bifidobacterium, a healthy microbiome is required to synthesize vitamins and facilitate mineral absorption. When the gut becomes inflamed, nutrient transport breaks down, establishing a vicious cycle where malnutrition accelerates gut permeability, and gut permeability deepens nutritional depletion.

The review notes that simply taking massive doses of supplements will not solve the problem. Several essential trace elements display narrow safety windows where excessive intakes accelerate oxidative stress or interfere with normal cellular defense. The real scientific priority is achieving physiological sufficiency. By identifying subclinical deficiencies,restoring mucosal integrity, and re-establishing microbial balance, targeted nutritional interventions offer a direct,practical route to calm systemic immune activation and protect biological vitality.

Actionable Insights

Maintaining baseline micronutrient sufficiency is essential to prevent intestinal barrier breakdown and quell chronic systemic inflammation. A critical clinical takeaway is that nutritional interventions demonstrate measurable, practical effect sizes primarily when correcting subclinical deficits rather than pushing supra-physiological levels.

In clinical trial data reviewed, specific targeted corrections yielded substantial absolute and relative gains. In adults with mild cognitive impairment and elevated homocysteine, combined B-vitamin supplementation (folate, B6, B12) alongside adequate omega-3 fatty acid levels reduced the annualized rate of whole-brain atrophy by up to 40 percent compared to placebo. Similarly, in large-scale hypertensive trials, daily folic acid supplementation achieved a 21 percent relative risk reduction for first stroke.

Practically, individuals should assess their serum 25-hydroxyvitamin D, active B12, folate, and erythrocyte magnesium, bringing low values into optimal physiological ranges. Supporting gut microbial diversity through dietary fiber and targeted vitamins fosters populations of Akkermansia and Faecalibacterium, expanding short-chain fatty acid output to tighten intestinal junctions. However, people must avoid unguided megadosing of zinc, selenium, or iron. These trace elements follow non-linear, U-shaped dose-response curves, where chronic excess promotes cellular toxicity, blocks competitive mineral uptake, and increases long-term morbidity.

Context/Source

  • Open Access Paper: Inflammaging and the role of micronutrients as immunomodulators: a pathway to healthy aging
  • Institutions: Haleon (Singapore); WNS Global Services (Gurugram, India); Centre for Environmental Life Sciences, Nanyang Technological University (Singapore)
  • Countries: Singapore and India
  • Journal Name: Immunity & Ageing
  • Impact Evaluation: The impact score of this journal is 6.5 (Journal Impact Factor) / 9.8 (CiteScore), evaluated against a typical high-end range of 0–60+ for top general science, therefore this is a High impact journal.

RapAdmin

AspirinGateGripMemoryMood-2
AspirinGateGripMemoryMood-21920×1072 306 KB

Researchers re-analyzed ASPREE, a large randomized trial of daily 100 mg aspirin versus placebo in 18,581 healthy adults aged 65 and older from Australia and the United States. They built an “intrinsic capacity” score from four domains measured each year: cognition, walking speed, grip strength and mood. They then checked the score against frailty, epigenetic clocks and the trial’s main outcome of dementia- and disability-free survival. The score behaved well. People in the lowest fifth had more than four times the risk of dementia, disability or death over about five years compared with those in the highest fifth. Aspirin did not slow the decline in capacity in either sex. In women, it was associated with a slightly faster decline.

Inflammation that simmers quietly in the body for years, often called inflammaging, is one of the leading suspects behind age-related decline. If it drives frailty, memory loss and weakness, a cheap anti-inflammatory drug might slow all of them. Aspirin is the obvious candidate. A new analysis of one of the largest aspirin trials ever run in older people says it does not work that way, and may slightly harm older women.

The data come from ASPREE, which randomized more than 19,000 healthy Australians and Americans, most of them over 70, to take either 100 mg of aspirin or an identical placebo every day. Its main results, published in 2018, showed that aspirin did not extend life free of dementia or disability. It increased serious bleeding, and overall deaths were slightly higher in the aspirin group. Critics countered that death and dementia are blunt, late-stage outcomes. Perhaps aspirin preserves function in subtler ways that take longer to show up as diagnoses.

To test that idea, a team led by Joanne Ryan at Monash University in Melbourne turned to a measure the World Health Organization calls intrinsic capacity. It is a single score that captures how well a person thinks, moves, grips and feels. Using yearly test results, the researchers combined memory and processing-speed tests, a short timed walk, hand-grip strength and a depression questionnaire into one number for each participant, every year, for up to seven years.

They first asked whether the score meant anything. It did. Capacity was lower in older participants and tracked closely with a 67-item frailty index. In women, lower capacity also lined up with faster aging on several epigenetic clocks, the DNA-based estimates of biological age. Most importantly, it predicted the future. People in the lowest fifth of capacity at the start were roughly four and a half times more likely to develop dementia, become disabled or die over the next five years than those in the top fifth.

Then came the aspirin test. Capacity fell steadily in everyone, as expected with age. Aspirin did not change that slope in men. In women, the aspirin group declined slightly faster than the placebo group. The researchers describe the difference as equivalent to one to two extra months of aging. A formal test of whether men and women truly responded differently came close to significance but did not reach it, so the sex difference should be treated as a lead to follow up, not a settled fact.

The authors point to a plausible culprit: anemia. Aspirin causes small, often unnoticed blood losses, and earlier ASPREE work found it raised the risk of anemia by about a fifth. Low hemoglobin has been linked to weaker muscles, slower walking, poorer cognition and lower mood, with women often more affected. However, this study did not directly test whether hemoglobin explains the result.

The practical message is plain. For healthy people in their 70s, daily low-dose aspirin is not a longevity or healthspan drug. If inflammaging is a real target, aspirin at this dose is the wrong tool.

Actionable insights

The headline finding is a null result, so the practical value lies mostly in what not to do, plus a useful self-monitoring tool.

Do not start daily low-dose aspirin to slow aging if you are over 60. It did not preserve capacity in men or women. The parent trial found more major bleeding (8.6 vs 6.2 events per 1,000 person-years, HR 1.38) and slightly higher all-cause mortality (HR 1.14). The US Preventive Services Task Force already recommends against starting aspirin for primary prevention at 60 or older. [Confidence: High]

Women saw a small extra decline. Women on aspirin lost capacity roughly 13% faster than women on placebo. That works out to about 1 to 1.5 months of extra functional aging per year of use, or roughly 5 to 7 months over the trial. It is too small to notice day to day, and the statistical evidence for a sex-specific effect is borderline.

If you take aspirin for a medical reason, such as a prior heart attack or stroke, this study does not apply. Do not stop without talking to your clinician.

If you take aspirin for any reason, especially as a woman, check hemoglobin and ferritin periodically.

Track your own function. Walking speed, grip strength, memory and mood predicted a roughly four-fold difference in risk of dementia, disability or death. They are cheap to measure at home or in a clinic.

Context and source

  • Open Access Paper: Validation of an intrinsic capacity index and the effects of aspirin in older males and females: secondary analysis of a randomized controlled trial
  • Institutions: School of Public Health and Preventive Medicine, Monash University (lead); University of Basel; Cedars-Sinai Health Sciences University; Hennepin Healthcare and Hennepin Healthcare Research Institute; Epigenetic Clock Development Foundation
  • Country: Australia (lead), with Switzerland and the United States
  • Journal: GeroScience (Springer). DOI 10.1007/s11357-026-02624-x
  • Impact evaluation: The impact score of this journal is 6.0, evaluated against a typical high-end range of 0 to 60+ for top biomedical journals, therefore this is a Medium impact journal.

RapAdmin

CognitionAgingAndReading-2
CognitionAgingAndReading-21920×1072 311 KB

Italian researchers tested 120 neurologically healthy adults aged 60 to 88 on a large battery of reading, attention, vision and cognitive tasks to find out what drives slower reading with age. Using statistical mediation, they found that general cognitive speed matters most. The Symbol Digit Modalities Test, which combines processing speed, working memory and inhibition, accounted for roughly a quarter to more than half of the age effect on reading speed, outperforming simpler reaction-time and Stroop measures. Visual acuity explained a small share of slowing on simple word lists. Visuo-spatial attention did not mediate the age effect but moderated it: people with poorer selective and focal attention showed steeper age-related slowing on word and pseudoword lists. Sustained attention and attentional orienting played no role.

Reading gets slower with age, even in healthy, well-educated people who read every day. Most of us assume the eyes are to blame. A new study from the University of Milano-Bicocca suggests the brain’s general processing speed is the bigger story, and that a specific kind of attention decides who slows down most.

The team tested 120 healthy Italians aged 60 to 88. Each spent up to two hours on reading tasks: lists of real words and invented pseudowords, presented tightly or widely spaced; a passage from a news magazine; and a test of reading unrelated words as fast as possible. They also completed vision charts, reaction-time tests, the Stroop color-word test, a finger-tapping test of sustained attention, a visual search task that separates different kinds of spatial attention, and the Symbol Digit Modalities Test, in which people match symbols to numbers against the clock.

Age predicted slower reading on every task. The question was why. Using a statistical method called mediation analysis, the researchers asked which abilities sit on the path between age and reading. The symbol-digit test came out on top. It explained more than half of the age-related slowing in reading the magazine passage and a large share for the other tasks. When it was analyzed alongside the reaction-time and Stroop tests, it absorbed their contribution entirely. The authors argue this is because the symbol-digit test bundles processing speed, working memory and the ability to ignore distraction into one demanding task, which is also what fluent reading requires.

Vision mattered too, but less. Visual sharpness explained a small slice of slowing on simple word lists, where cognitive load is light. For harder material such as pseudowords and continuous text, cognition dominated.

The authors’ main hypothesis concerned selective visuo-spatial attention, the brain’s ability to spotlight one location and suppress clutter around it. They expected it to sit on the causal path. It did not. Instead, it changed the strength of the age effect. Among people with weaker selective attention, reading time climbed steeply with age; among those with strong attention, the age slope was much flatter. At around 80, the difference on a word list amounted to roughly ten seconds out of thirty to forty. A narrower “focal” component of attention behaved similarly, while the ability to shift attention between locations had no effect. Sustained attention, the capacity to stay on task, was also irrelevant.

The practical message the authors draw is that general processing speed is hard to train, but visual attention may be a more specific and trainable target. The same group has already piloted eye-controlled video games for older readers.

There are limits. The study compares different people at different ages rather than following anyone over time, which makes causal language about “decline” premature. Many of the tests share a dependence on speed, which can inflate apparent links. The attention findings emerged only after the planned analysis failed, and several rested on borderline statistics.

Still, the study reframes reading in later life as a readout of attentional health, not just eyesight.

Actionable insights

The study tests no intervention, so these points follow from its associations plus one related trial.

How big is the age effect? On the speed-reading test, scores fell by roughly 18 words per minute per decade, about 14% of the group average. For simple word lists, reading time rose about 8 seconds per decade, roughly 30% of the average. [Confidence: Medium, back-calculated from standardized coefficients]

Processing speed is the main channel. The symbol-digit test carried about 57% of the age effect on reading a news passage and about 43% on speed reading. Habits that preserve general cognitive speed are therefore the most relevant lever, though none were tested here. [Confidence: Medium]

Keep your vision corrected. Visual acuity explained only about 6 to 7% of the age effect, and only for simple word lists. It is still the cheapest factor to fix: get regular eye exams that include near-vision correction. [Confidence: Medium]

Attention training is plausible but unproven. The same lab enrolled 40 healthy participants over 65 in an eye-guided video game pilot. Reading improved, but attentional measures did not change.

Noticeable slowing in reading unfamiliar or dense text is worth tracking as a cognitive signal, not as a diagnosis.

Context and source

  • Open Access Paper: Reading in healthy aging: how attentional components drive age-related changes
  • Institutions: Department of Psychology, University of Milano-Bicocca; NeuroMI Milan Centre for Neuroscience; Golgi Cenci Foundation (Abbiategrasso); Mercatorum University (Rome); LUMSA University (Rome)
  • Country: Italy
  • Journal: Aging Clinical and Experimental Research (Springer). DOI 10.1007/s40520-026-03535-9
  • Impact evaluation: The impact score of this journal is 4.7, evaluated against a typical high-end range of 0 to 60+ for top biomedical journals, therefore this is a Low impact journal.

RapAdmin

HeartDiseaseAndTCells-2
HeartDiseaseAndTCells-21920×1072 309 KB

Coronary artery disease often progresses silently for years before causing symptoms. A cross-sectional clinical study of 967 middle-aged Swedish adults from the SCAPIS cohort investigated whether shifts in adaptive and innate immunity relate to hidden plaque buildup. Using multi-color flow cytometry on fresh whole blood and coronary computed tomography angiography, researchers identified an immunosenescent profile in individuals harboring 50 percent or greater asymptomatic coronary artery narrowing. These individuals demonstrated an expansion of central memory CD4 positive T cells alongside depleted levels of naive CD4 positive T cells, naive regulatory T cells, and CD56bright natural killer cells. Standard coronary artery calcium scoring failed to detect these immune alterations, emphasizing its inability to track early non-calcified lesions. These findings indicate that accelerated immune aging and defective regulatory tolerance accompany subclinical coronary obstruction, presenting cellular targets for longevity therapeutics.

Cardiovascular disease remains the leading cause of mortality worldwide, yet its earliest stages develop without symptoms inside the arterial wall. For decades, the dominant clinical paradigm has framed atherosclerosis primarily as a mechanical lipid clearance problem. The Swedish CArdioPulmonary bioImage Study (SCAPIS) challenges this narrow perspective by establishing that premature aging of the adaptive immune system closely shadows the silent, structural narrowing of coronary arteries.

The primary breakthrough rests on the timing and location of immune decay. Prior investigations into immune exhaustion typically studied patients who had already suffered myocardial infarctions or presented with unstable angina. By evaluating 967 middle-aged individuals between 50 and 64 years of age with no history of coronary events, the authors captured the immune system at the asymptomatic crossroad where prevention is still possible. Using fresh whole blood samples rather than frozen specimens, the investigators preserved delicate cell surface phenotypes that previous population surveys lost during freeze-thaw cycles.

The researchers mapped immune cell subsets against advanced coronary computed tomography angiography (CCTA), an imaging modality capable of visualizing both soft non-calcified plaques and true luminal obstruction. The data demonstrated that individuals with significant subclinical stenosis (50 percent or greater luminal narrowing) suffered from a pronounced disruption in their T cell balance. Their immune systems were depleted of naive CD4 positive T cells and enriched with central memory CD4 positive T cells. Naive T cells represent the immune reserve, equipped to handle novel antigens and maintain tolerance, while memory cells reflect prior antigen encounters and cellular wear. In these patients, the cellular equilibrium shifted toward exhaustion.

Equally telling was the depletion of naive regulatory T cells (Tregs) and CD56bright natural killer cells. Regulatory T cells suppress excessive immune activation and protect arterial tissue from auto-inflammatory damage. When naive Tregs disappear, the body loses its front-line defense against inflammatory damage in the vascular endothelium.

A critical revelation emerged when comparing CCTA with traditional coronary artery calcium (CAC) scoring. While calcium scans are widely utilized for cardiovascular risk stratification, CAC scores showed zero independent associations with immune cell aging phenotypes once age and sex were accounted for. Calcium scans only detect mineralized, hard plaque, missing vulnerable non-calcified plaques and early vascular inflammation. Relying solely on calcium scores may therefore foster false reassurance. The immune system signals vascular distress long before mineralized scar tissue consolidates.

This investigation links systemic immunosenescence directly to vascular degeneration. Strategies aimed at preserving the naive T cell pool, preventing thymic decline, and dampening chronic baseline inflammation could represent actionable pathways to keep coronary arteries resilient throughout the human lifespan.

Actionable Insights

This study reveals that silent coronary disease does not merely correlate with cholesterol numbers, but is tightly intertwined with the internal age of your immune cells. Statistical modeling demonstrated measurable changes in disease odds based on cell levels:

Each 10 percent increase in the proportion of naive regulatory T cells was associated with an approximate 9.2 percent reduction in the odds of having 50 percent or greater coronary narrowing.

Each 10 percent increase in central memory CD4 positive T cells was linked to a 12.9 percent higher odds of significant arterial stenosis.

Each 10 percent increase in effector memory CD4 positive T cells was associated with a 6.6 percent reduction in the odds of severe stenosis.

To translate these findings into health optimization, individuals should address the primary lifestyle and metabolic drivers that accelerate immune aging. Visceral adiposity, elevated fasting glucose, systemic interleukin-18, and cytomegalovirus infection were all associated with accelerated immune degradation. Maintaining optimal body composition, maintaining insulin sensitivity through resistance training, ensuring restorative sleep, and supporting immune health with sufficient micronutrients like zinc and vitamin D preserve naive T cell reserves. Clinicians and health-conscious adults must also recognize that a zero coronary calcium score does not rule out soft, inflamed coronary plaque. Comprehensive cardiovascular evaluations should consider direct anatomical visualization via coronary CTA where indicated.

Context and Source

RapAdmin

EarlyAerobicExercisePreventSarco-2
EarlyAerobicExercisePreventSarco-21920×1072 343 KB

Sarcopenia is typically diagnosed late in life, yet its cellular foundations develop decades before clinical symptoms emerge. This investigation examined gastrocnemius muscle remodeling in male Wistar rats between young adulthood (8 months) and middle age (14 months), corresponding roughly to 22 and 35 human years. The authors evaluated whether lifelong moderate aerobic treadmill running mitigates early muscle deterioration. Sedentary aging caused an 18.2 percent decline in relative gastrocnemius muscle mass, accompanied by fiber cross-sectional area heterogeneity, selective fiber atrophy, and compensatory hypertrophy in surviving fibers. Concurrently, citrate synthase activity plummeted, forcing tissue toward glycolytic reliance, basal AMP-activated protein kinase activation, and anti-apoptotic signaling. Lifelong aerobic exercise completely prevented the loss of relative muscle mass, sustained mitochondrial enzyme activity, and stabilized baseline cellular energetics. These data establish that structural and metabolic sarcopenic decline begins in early adulthood and can be largely mitigated through sustained aerobic conditioning.

The standard clinical approach to muscle loss operates under a significant blind spot. Diagnostic criteria for sarcopenia generally trigger only when elderly patients present with overt frailty, reduced walking speed, or visible wasting. By that point, the biological machinery required for functional recovery has been deteriorating for decades. A study conducted in Portugal challenges this late-stage model, demonstrating that skeletal muscle enters a state of structural and metabolic crisis by early middle age, long before gross physical wasting becomes obvious.

Tracking male Wistar rats from young adulthood (8 months of age) to middle age (14 months of age), corresponding to human ages 22 and 35, the researchers assessed the gastrocnemius, a fast-twitch, mixed-fiber lower limb muscle vulnerable to age-related atrophy. In sedentary animals, absolute muscle mass remained superficially steady. However,when normalized against total body weight to derive the sarcopenia index, middle-aged sedentary animals experienced a sharp loss in relative muscle mass.

Histological inspection revealed that this decline was not uniform across all tissue. Instead, middle-aged muscles exhibited profound structural heterogeneity. Individual muscle fibers showed atrophic shrinking, while neighboring fibers enlarged drastically. This pattern represents compensatory hypertrophy: surviving fibers expand their cross-sectional area to shoulder the mechanical load left by dying or denervated neighbors.

Underneath this structural remodeling lies an energetic deficit. Sedentary middle-aged muscles suffered an acute collapse in citrate synthase activity, an enzymatic marker of mitochondrial density. Deprived of normal oxidative capacity, the muscle tissue was forced into an inefficient metabolic shift, leaning heavily on anaerobic glycolysis for basic ATP maintenance. This energy crisis was reflected in the elevated activation of the cellular fuel sensor, AMP-activated protein kinase, alongside an upregulation of the anti-apoptotic protein BCL2A1. The tissue effectively entered a compensatory survival state, suppressing cell death programs to preserve whatever functional fibers remained.

The positive outcome of the investigation centers on lifelong physical conditioning. Animals subjected to regular,moderate treadmill running over their lifespan completely bypassed this cascade. Exercised middle-aged rats maintained their youthful relative muscle mass, sustained citrate synthase activity, avoided the compensatory glycolytic shift, and showed normalized baseline cellular energy sensing. Notably, this protection occurred without changes in common catabolic markers such as atrogin-1 or classic oxidative protein damage markers, which remained unchanged across all cohorts. The primary takeaway is clear: the metabolic decay of sarcopenia is an early middle-age phenomenon, and consistent aerobic conditioning provides an effective, highly accessible defense.

Actionable Insights

Sarcopenia does not start in retirement; functional muscle loss begins in early adulthood. In this rodent model, the relative muscle-to-body-weight ratio declined by 18.15 percent between young adulthood and middle age. Concurrently,mitochondrial density collapsed by over 90 percent in sedentary subjects.

Lifelong aerobic exercise completely abolished this loss, yielding a 23.65 percent advantage in relative muscle mass over sedentary peers. Translated to standardized statistics, the intervention produced a massive effect size (Cohen’s d = 3.77),indicating that regular endurance running effectively shielded muscle architecture from middle-aged degradation.

For human health, the takeaway is straightforward: do not wait for strength declines or physical frailty in your 60s to prioritize physical conditioning. Sustained aerobic exercise, conducted at roughly 70 percent of peak capacity for 45 to 60 minutes multiple times per week, preserves mitochondrial enzyme activity and prevents the covert muscle fiber loss that forces remaining tissue into overstretched, compensatory hypertrophy. Aerobic exercise should be maintained consistently throughout young adulthood and middle age to protect metabolic flexibility, prevent excessive fat accumulation relative to lean mass, and preserve muscle quality before irreversible loss occurs.

Context/Source

  • Open Access Paper: Exploring the effects of lifelong aerobic exercise on early skeletal muscle remodeling between 8 and 14 months in the rat
  • Institutions: Research Center in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sport, University of Porto; LAQV-REQUIMTE, Department of Chemistry, University of Aveiro; Centre for Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro; UCIBIO, University Institute of Health Sciences (IUCS-CESPU); Institute of Biomedicine (iBiMED), University of Aveiro Country: Portugal
  • Journal Name: Journal of Physiology and Biochemistry
  • Impact: The impact score of this journal is 3.4, evaluated against a typical high-end range of 0 to 60+ for top general science,therefore this is a Medium impact journal.

RapAdmin

WholeFoodsAgingBrain-2
WholeFoodsAgingBrain-21920×1072 324 KB

A cross-sectional investigation of 1,017 community-dwelling older adults from the Birjand Longitudinal Aging Study demonstrated that individuals consuming the highest amounts of unprocessed or minimally processed foods experienced a 48 percent reduction in the odds of major neurocognitive disorder compared to the lowest consumers. While contemporary public health messaging frequently identifies ultra-processed foods as major drivers of cognitive decay, this study observed no statistically meaningful association between ultra-processed intake and cognitive impairment. The primary dietary determinant of late-life cognitive preservation in this cohort was the proactive inclusion of nutrient-dense,intact food staples rather than the strict avoidance of industrially formulated items. These older Iranian adults ate relatively little ultra-processed food to begin with, so the study may simply have lacked the range to detect a harm.

The contemporary conversation surrounding human nutrition and brain longevity has focused heavily on the perils of ultra-processed food. From packaged snacks to industrial ready-meals, public health discourse suggests that manufactured foods actively degrade cognitive function. However, emerging observational evidence from populations outside Western nations suggests that what is omitted from the plate may matter substantially more than what is added. An investigation published in Aging Clinical and Experimental Research examining community-dwelling older adults indicates that high intake of unprocessed, intact foods exerts a substantial protective association against major neurocognitive disorders,while ultra-processed food intake shows no statistically meaningful link to cognitive deterioration.

Researchers evaluated 1,017 older adults participating in the second wave of the Birjand Longitudinal Aging Study in eastern Iran. Unlike Western demographic cohorts where ultra-processed products routinely supply over half of total daily calories, this cohort adheres to a more traditional culinary baseline. The investigators classified dietary intake using the NOVA classification system, which categorizes foods according to the extent and purpose of industrial processing.Cognitive status was determined through formal clinical neurological evaluations using Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria, comprehensive neuropsychological test batteries, functional independence scoring,and structural brain magnetic resonance imaging when indicated. In total, 13.8 percent of the cohort met the clinical threshold for major neurocognitive disorder.

Analyzing dietary composition against neurological outcomes revealed a striking divergence. Participants consuming the highest tertile of unprocessed and minimally processed foods, such as fresh vegetables, fruits, whole grains, legumes, and intact meats, experienced a 48 percent reduction in the odds of major neurocognitive disorder compared to the lowest tertile, after rigorous adjustment for age, sex, education, physical activity, smoking, depressive symptoms, and total caloric intake. Every 10 percent increment in daily energy derived from unprocessed foods was associated with an additional 9 percent reduction in neurocognitive disorder odds. In addition, moderate consumption of traditional culinary ingredients, including basic vegetable oils, salt, and seasonings, reduced impairment odds by 52 percent, reflecting the neuroprotective benefit of home-prepared meals.

Conversely, ultra-processed food consumption exhibited no statistically significant relationship with neurocognitive impairment in any statistical model. Participants in the highest tertile of ultra-processed food intake demonstrated no verified elevation in disorder risk compared to those in the lowest tertile. Because the median ultra-processed food intake across the cohort was modest, representing approximately 130 kilocalories daily or roughly eight percent of total caloric intake, the findings demonstrate that low levels of industrial food consumption do not inherently undermine cognitive health.

These results challenge common dietary assumptions. Cognitive resilience in late life appears less reliant on obsessive avoidance of minor industrial ingredients and far more dependent on establishing a robust foundation of intact, nutrient-dense foods. Diets built around whole foods provide essential polyphenols, fermentable fibers, and micronutrients that suppress cerebral oxidative stress and sustain neuronal vitality. For clinicians and longevity professionals, the takeaway is clear: prioritizing the proactive addition of intact, whole-food calories offers measurable neuroprotection that far exceeds the passive elimination of processed convenience products.

Actionable Insights

To support long-term cognitive health, individuals should shift their focus from obsessively eliminating packaged foods to deliberately meeting a daily threshold of intact, unprocessed foods. In this older cohort, participants with normal cognitive function consumed an average of 760 daily kilocalories from unprocessed sources compared to 670 kilocalories among impaired peers. This absolute difference of roughly 90 kilocalories per day, equivalent to a single apple, one cup of cooked legumes, or a modest serving of chicken breast, correlated with a 48 percent relative reduction in the odds of developing a major neurocognitive disorder.

On a continuous scale, every 10 percent increase in the proportion of total daily calories derived from whole foods yielded an additional 9 percent drop in disorder odds. Furthermore, moderate use of basic culinary ingredients such as unrefined cooking oils and natural seasonings in home-prepared meals was associated with a 52 percent reduction in cognitive impairment odds. The practical prescription for longevity is straightforward: ensure that at least 50 to 60 percent of your daily caloric intake is composed of single-ingredient, unrefined foods including vegetables, fruits, whole grains, nuts, and minimally processed proteins, which provides an effective neuroprotective buffer regardless of occasional convenience food intake.

Context and Source

RapAdmin

EmpagliflozinInflammation-2
EmpagliflozinInflammation-22752×1536 447 KB

Sixteen women who were obese and had blood sugar levels on the edge of diabetes took empagliflozin, a common diabetes drug, every day for twelve weeks. Doctors drew their blood three times: before they started, after two weeks, and at the end. They were looking for a particular troublemaker in the blood. Platelets are the tiny cells that help blood clot, and when they get activated they sometimes stick to white blood cells called monocytes. The clumps they form stir up inflammation and have been tied to heart disease. The researchers used a technique that reads the genes of one cell at a time, and they went to real effort to prove these clumps were actual clumps and not just two cells accidentally measured together, including photographing them under a microscope. After twelve weeks on the drug, the clumps were noticeably less common, dropping by roughly 40 percent, and the platelets still attached to them looked less activated. Free monocytes went up as the clumps went down, and the total number of platelets stayed the same. A small group of four women who had tried cutting calories instead of taking the drug showed no such change.

SGLT2 inhibitors have an unexplained surplus. In the large cardiovascular outcome trials they prevent more heart failure hospitalizations and cardiovascular deaths than their effects on glucose, weight, or blood pressure can account for. The leading candidate explanation is that they do something to inflammation. Nobody has shown clearly what.

A Vanderbilt group went looking inside human immune cells. They took 16 women with obesity and prediabetes, gave them empagliflozin 25 mg daily for 12 weeks, and drew blood at baseline, 2 weeks, and 12 weeks. Eight of those sample sets went through single-cell RNA sequencing.

Their target was an object that is easy to miss. When platelets become activated, some of them latch onto circulating monocytes, forming a hybrid complex called a monocyte-platelet aggregate. These aggregates are more inflammatory than either partner alone and have been linked to cardiovascular disease.

Finding them in sequencing data is harder than it sounds, because a monocyte with a platelet stuck to it looks very much like two cells accidentally captured in one droplet, which is the field’s classic artifact. The team spent most of their effort ruling that out. They computationally excluded technical doublets. They built artificial aggregates by digitally fusing a platelet transcriptome to a monocyte transcriptome from the same person, and showed the real ones looked different. Then they went to the microscope and photographed platelets physically bound to monocytes.

Having established the population was real, the result was straightforward. After empagliflozin, these aggregates became less common. A Bayesian model put the reduction at 5.0 percentage points by 12 weeks, with a credible interval comfortably away from zero. Classical monocytes rose correspondingly, which is what you would expect if aggregates were simply dissociating back into free monocytes. Platelet frequency did not change. The platelet activation marker on the remaining aggregates fell too.

Four women from an earlier study who had done 14 weeks of calorie restriction instead showed no such change. The authors read this as evidence that the effect is drug-specific rather than a consequence of weight loss.

The transcriptional picture is where it gets interesting and slightly strange. Twelve weeks of empagliflozin pushed monocytes toward oxidative phosphorylation, which fits the standard immunometabolic story in which inflammatory cells run on glycolysis and quieter cells run on mitochondria. But the same analysis showed increased mTORC1 and PI3K/AKT/mTOR signaling, which is an anabolic growth program, not an obvious anti-inflammatory one. The authors describe this as a coordinated shift toward a more homeostatic phenotype, which is plausible but is an interpretation rather than a demonstration.

And the functional assay disagreed. When they measured actual metabolic activity and fuel dependence in these cells, empagliflozin changed nothing.

This is a pilot study of eight people, all women, all White, with no placebo arm and no randomization.

Actionable Insights

The study identifies a plausible mechanism. Empagliflozin reduced monocyte-platelet aggregates by roughly 40 percent in relative terms over 12 weeks, in a group of eight people. That is a reasonably large effect on the marker.

The effect appeared independent of weight and glucose. Aggregate frequency did not track either. For anyone taking an SGLT2 inhibitor primarily for metabolic reasons, this suggests an additional pathway is engaged. Note that with only seven or eight people, the study had almost no ability to detect such correlations even if they exist, so read this as unconfirmed rather than established.

The diet comparison is weaker than it sounds. Four people showed no change. Four people would not reliably show a change even if calorie restriction were genuinely effective. The conclusion that empagliflozin “uniquely” reduces these aggregates is not supported by that arm.

Timing matters. Most of the effect was present by 2 weeks and grew modestly by 12. This is a fast pharmacodynamic response, not a slow remodeling.

Context and Source

  • Paywalled Paper: SGLT2 Inhibitor Empagliflozin Reduces Circulating Monocyte-Platelet Aggregates: A Pilot Study, published September 15, 2026
  • Institutions: Vanderbilt University Medical Center and Vanderbilt University, Nashville, with the Tennessee Valley VA Healthcare System, UT Southwestern Medical Center, and the VA Geriatric Research Education Clinical Center
  • Country: United States
  • Journal: Circulation (American Heart Association / Lippincott Williams & Wilkins),
  • Impact evaluation: The impact score of this journal is 38.6, evaluated against a typical high-end range of 0 to 60+ for top general science, therefore this is an Elite impact journal.

相关阅读：

RapAdmin

SleepThyroidHealth-2
SleepThyroidHealth-22752×1536 464 KB

Using data from 499,084 UK Biobank participants aged 37 to 73, researchers at Harbin Medical University built a 0-to-5 healthy sleep score from five self-reported habits: 7 to 8 hours of sleep, morning chronotype, no frequent insomnia, no snoring and no frequent daytime sleepiness. Over roughly 12 years of follow-up, about 15,000 people were diagnosed with thyroid disease. Compared with those scoring 0 or 1, people with a perfect score of 5 had about 24% lower adjusted risk of any thyroid disease, 25% lower risk of hypothyroidism, 26% lower risk of nontoxic goiter and 32% lower risk of thyrotoxicosis. No association was seen for thyroiditis or thyroid cancer. Not feeling excessively sleepy during the day was the strongest single component.

Poor sleep has been linked to almost every chronic disease researchers have gone looking for. Now a team from Harbin Medical University in China has added the thyroid to the list. Using health records from about half a million middle-aged and older adults in the UK Biobank, they report that people with the healthiest sleep habits were roughly a quarter less likely to be diagnosed with thyroid disease over the following decade or so.

At enrollment between 2006 and 2010, the researchers scored each participant from 0 to 5, awarding a point for each of five habits: sleeping 7 to 8 hours, being a morning person, rarely having insomnia, not snoring, and not often dozing off during the day. They then followed medical records until early 2022. About 15,000 people developed a thyroid condition, most commonly an underactive thyroid.

After accounting for age, sex, body size, income, education, smoking, drinking, exercise and diabetes, each extra healthy habit was linked to a stepwise drop in risk. People with a perfect 5 had 24% lower risk of any thyroid disease than those scoring 0 or 1, 25% lower risk of an underactive thyroid, 26% lower risk of goiter and 32% lower risk of an overactive thyroid. There was no link with thyroid cancer or thyroiditis.

In absolute terms the difference is modest. Among the poorest sleepers, about 4 in 100 were diagnosed with thyroid disease during follow-up, compared with about 2.6 in 100 among the best sleepers. After adjustment, the gap shrinks to roughly 1 in 100.

The single habit that mattered most was not feeling excessively sleepy during the day. People who only rarely or sometimes dozed off had about 20% lower risk of thyroid disease overall and nearly 40% lower risk of an overactive thyroid. Snoring made no difference.

That standout finding is also the study’s biggest weakness. Daytime sleepiness is less a habit than a symptom, and fatigue and sleepiness are classic early signs of an underactive thyroid. Thyroid disease often smolders for years before diagnosis. Some participants who reported poor sleep may therefore already have had a faltering thyroid, which would make sleep look like a cause when it is actually an early consequence. The authors excluded people diagnosed in the first year of follow-up, but that does little for a condition that can develop silently over many years. No baseline thyroid blood tests were available to rule it out.

There are plausible biological reasons sleep could matter. Thyroid-stimulating hormone follows a daily rhythm that peaks at night, and sleep loss disturbs that rhythm. Animal studies show sleep deprivation also pushes the immune system toward inflammation and autoimmunity, which is the main driver of both underactive and overactive thyroid disease in iodine-sufficient countries.

Still, people who sleep well also tend to be leaner, wealthier, more active and less likely to smoke, and statistical adjustment rarely erases such differences completely. The study cannot establish cause and effect.

It does add the thyroid to a long list of reasons to protect sleep. And it carries a practical message that may be more useful than the headline: persistent daytime sleepiness deserves a medical look, and a simple thyroid blood test belongs in that workup.

Actionable insights

The habits in the score are worth pursuing for many reasons: aim for 7 to 8 hours, keep a consistent schedule that leans earlier, and treat chronic insomnia (cognitive behavioral therapy for insomnia is the first-line approach).

How big is the effect? Results are reported as hazard ratios (HR), which compare the rate of new diagnoses between groups; an HR of 0.76 means a 24% lower rate. Scoring 5 versus 0 or 1 was linked to an HR of 0.76 for any thyroid disease. Each additional healthy habit tracked with roughly 6 to 8% lower risk.

In absolute terms, that is about 1 fewer diagnosis per 100 people over about 12 years. Put another way, roughly 100 people would need to move from the worst to the best sleep pattern to prevent one thyroid diagnosis, and only if the link is causal. For overactive thyroid alone, the figure is closer to 400.

The most actionable message may run in the opposite direction. If you have persistent, unexplained daytime sleepiness or fatigue, ask for a TSH and free T4 test. If sleepiness comes with loud snoring or witnessed pauses in breathing, ask about sleep apnea testing too.

The associations appeared slightly stronger in women and in overweight adults, but the subgroup differences were small.

Context and source

  • Open Access Paper: Healthy sleep pattern is associated with reduced risk of incident thyroid disease: a prospective cohort study from the UK Biobank
  • Institutions: Department of Endocrinology and Metabolism, Second Affiliated Hospital of Harbin Medical University; School of Public Health, Harbin Medical University; Key Laboratory of Precision Nutrition and Health, Ministry of Education
  • Country: China (analysis of UK data)
  • Journal: Frontiers in Endocrinology, published 2 October 2026.
  • Impact evaluation: The impact score of this journal is 4.6 (most recent listed Journal Impact Factor; 5-year JIF 5.2; JCR Q1, ranked about 43rd of 191 in Endocrinology and Metabolism), evaluated against a typical high-end range of 0 to 40+ for endocrinology and metabolism, therefore this is a Medium impact journal.

相关阅读：

RapAdmin

ObesityCancerRisk16_9-2
ObesityCancerRisk16_9-22752×1536 479 KB

Using South Korea’s national health insurance database, researchers followed 6,313,338 adults aged 20 to 39 who had a health screening between 2009 and 2012, for an average of 11.2 years. Height, weight and waist were measured, not self-reported. A total of 151,893 cancers were diagnosed. Ten-year cancer incidence rose stepwise from 1.84% at normal weight to 2.24% in class I obesity and 2.62% in class II obesity (Asian criteria: BMI 25 to 29.9 and 30 or higher), corresponding to adjusted hazard ratios of 1.22 and 1.43. Abdominal obesity added risk at every BMI level. Relative associations were stronger in men, but absolute excess risk was larger in women. Endometrial cancer showed the strongest relative link, and premenopausal breast cancer was less common with obesity. Absolute risk differences were small (under 1 percentage point over 10 years).

Cancer is increasingly a disease of the young. Rates of colorectal, endometrial, kidney and pancreatic cancer have been climbing among adults under 50 in many countries, and rising obesity has long been a prime suspect. A study of more than 6.3 million young South Korean adults now offers some of the clearest evidence yet that excess weight in your 20s and 30s is linked to cancer before middle age.

Researchers at the Catholic University of Korea and Soongsil University drew on the national health insurance database, which covers virtually the entire population and offers health checkups every two years. They took everyone aged 20 to 39 who had a checkup between 2009 and 2012, recorded their measured height, weight and waist size, and tracked insurance claims through the end of 2021, about 11 years on average.

About 152,000 people, or 2.4%, were diagnosed with cancer. Risk rose step by step with body weight. Over ten years, 1.84% of normal-weight participants developed cancer, compared with 2.24% in the first obesity class and 2.62% in the second. After accounting for age, sex, smoking, drinking, exercise, income and metabolic conditions, the heaviest group had a 43% higher cancer rate.

Two details matter for readers outside Asia. First, the study used Asian weight categories, which have lower cutoffs than Western ones. “Class I obesity” here means a body mass index of 25 to 29.9, which most Western guidelines call overweight. Second, where fat sits counts. People in that class I group who also carried a large waist had a higher ten-year cancer risk than people with a higher BMI but a smaller waist.

The pattern differed by sex. In relative terms the link was stronger in men. Young women develop more cancer to begin with, mainly thyroid, breast, cervical and ovarian, so the absolute excess was larger in women. Endometrial cancer showed the strongest relative link, consistent with fat tissue converting other hormones into estrogen. Breast cancer before age 50 went the other way and was slightly less common with obesity, a pattern seen before for premenopausal breast cancer.

The proposed biology is familiar. Excess fat, especially abdominal fat, drives chronic inflammation, high insulin and growth-factor signaling, and hormonal shifts that favor tumor growth. Starting that exposure earlier in life means more years of it.

There are important caveats. The absolute numbers are small: the heaviest group had less than one extra cancer per 100 people over ten years. Thyroid cancer was among the biggest contributors, and South Korea is known for overdiagnosing small, mostly harmless thyroid cancers through ultrasound screening. Heavier people, who see doctors more often, may simply have had more of them found. Cancers not usually considered obesity-related also rose with weight, which hints that part of the signal reflects detection or factors the data could not capture, such as diet or lifetime smoking.

Still, the clear dose-response, the waist findings and the sheer size of the cohort make a persuasive case. Weight, and especially waistline, in early adulthood looks like a meaningful lever on cancer risk, and it operates well before the ages when routine cancer screening begins.

Actionable insights

Measure your waist, not just your weight. A waist of 90 cm (35.4 in) or more in men, or 85 cm (33.5 in) or more in women, added cancer risk at every BMI level in this study. Those are Asian thresholds. Common Western cutoffs are higher (102 cm and 88 cm in US guidance), but this study suggests lower thresholds may matter for some people.

How big is the effect? Results are reported as hazard ratios (HR), where 1.22 means a 22% higher rate of new cancers. Compared with a BMI of 18.5 to 22.9:

  • BMI 25 to 29.9: HR 1.22, about 1 extra cancer per 250 people over 10 years.
  • BMI 30 or higher: HR 1.43, about 1 extra cancer per 128 people over 10 years.
  • BMI 25 to 29.9 plus a large waist: HR 1.34, about 1 extra cancer per 165 people over 10 years.

If causal, roughly 8% of cancers in this young cohort would be attributable to excess weight. That is a rough estimate from the paper’s numbers.

Absolute risk at these ages is low. The payoff from a healthy weight compounds over decades, because obesity-related cancers become much more common after 50.

Women with obesity should not dismiss abnormal uterine bleeding, since endometrial cancer showed the strongest relative link.

This study did not test whether losing weight lowers risk.

Context and source

  • Paywalled Paper: Obesity and Cancer Risk in Young Adults in Korea: A Nationwide Health Screening Cohort Study, Published October 27, 2026.
  • Institutions: College of Medicine, The Catholic University of Korea (St. Vincent’s, Bucheon St. Mary’s and Yeouido St. Mary’s Hospitals); Department of Statistics and Actuarial Science, Soongsil University; Samsung Biomedical Research Institute, Sungkyunkwan University
  • Country: South Korea
  • Journal: Annals of Internal Medicine (American College of Physicians)
  • Impact evaluation: The impact score of this journal is about 15 to 17 (sources differ: 15.4 in the 2025 JCR per one tracker and 17.3 per another; 5-year JIF about 20; Q1), evaluated against a typical high-end range of 0 to 100+ for general and internal medicine, therefore this is a High impact journal.

相关阅读：